Twitter Poison Pill Aims to Bloat the Company with More Shares Blocking Elon Musk’s Acquisition of the Social Media Company

In an attempt to block the acquisition of the company by Elon Musk, the Twitter (NYSE:TWTR) Board of Directors announced a Poison Pill plan today. The move was predicted following Musk’s announcement he wanted to take the company private at a per-share price of $54.20… Read More
Read more in: Featured Headlines, Fintech | Tagged david sacks, jason calacanis, twitter